González Díaz, M., Ellahioui, Y., Álvarez Lozano, R., Gallego-Yerga, L., Caballero Salvador, E., Vicente-Blázquez, A., . . . Peláez Lamamie de C. Arroyo, R. (2019). The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors.
Citación estilo ChicagoGonzález Díaz, Myriam, et al. The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions On Combretastatin and Isocombretastatin Tubulin Inhibitors. 2019.
Cita MLAGonzález Díaz, Myriam, et al. The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions On Combretastatin and Isocombretastatin Tubulin Inhibitors. 2019.